Testolone 5mg/tab 30 Tablets by Vital Research

Usage

1. Define your goal phase before purchasing: cutting (Ostarine + Cardarine partner stack) or bulking (LGD-4033 partner stack) — the RAD-140 dose and stack duration differ between phases.
2. Draw baseline bloodwork — total testosterone, LH, FSH, and a full metabolic panel — before the first tablet to create a valid pre-stack reference point.
3. Begin at 5 mg RAD-140 (one tablet daily) in week one regardless of the stack phase; this ramp-in period allows you to detect any unexpected individual sensitivity before committing to higher doses.
4. Take the daily tablet at a consistent time with your first substantial meal of the day to promote steady absorption alongside the other stack compounds.
5. Log strength benchmarks, body weight, and subjective recovery every week — structured tracking lets you attribute changes to RAD-140's contribution within the broader stack rather than conflating compound effects.
6. Discontinue all stack compounds simultaneously at the end of the planned cycle; do not taper one compound while continuing others, as this distorts the hormonal recovery signal and complicates post-cycle bloodwork interpretation.

Warnings

Frequently asked questions

What is the best SARM stack for cutting body fat while keeping muscle?

The most researched cutting stack combines RAD-140 (5–10 mg/day), Ostarine (10–20 mg/day), and Cardarine GW-501516 (10–20 mg/day). RAD-140 anchors anabolic signalling, Ostarine provides anti-catabolic protection under a deficit, and Cardarine activates PPARδ-driven fat oxidation. Together they address three distinct metabolic pathways simultaneously, which is why this combination dominates cut-phase SARM protocols in research community literature.

Can you stack LGD-4033 and RAD-140 together for a bulking cycle?

Yes — LGD-4033 and RAD-140 are frequently combined for bulking because their androgen receptor binding profiles are distinct, producing additive rather than redundant anabolic stimulation. A common starting point is LGD-4033 at 5–10 mg/day alongside RAD-140 at 5–10 mg/day for 6–8 weeks. Vital Research's 5 mg tablet format makes dose titration straightforward when running both compounds concurrently.

How long should a RAD-140 bulking or cutting stack run before a break?

Research protocols typically cap RAD-140 stacks at 6–8 weeks regardless of goal phase. Beyond this window, cumulative androgen receptor exposure without a washout period increases the complexity of recovery. Bloodwork at baseline and at the end of the cycle — measuring total testosterone and LH — provides the objective data needed to determine the appropriate length of any post-cycle recovery interval.

Why is Vital Research Testolone dosed at 5mg per tablet instead of a higher concentration?

The 5 mg tablet is designed for stack precision. When combining two or three SARMs simultaneously, the ability to dial in each compound's contribution in 5 mg increments prevents unintentional dose stacking errors. It also allows beginners to start at a single tablet per day (5 mg RAD-140) before assessing their personal response — a meaningful advantage compared to higher-concentration formats that lock users into larger starting doses.

Can Vital Research Testolone tablets be split or taken at different times of day?

Each 5 mg tablet is the minimum functional unit and is not designed for splitting below that dose. RAD-140's reported half-life of approximately 16–20 hours (based on pharmacokinetic modelling data) supports once-daily dosing, eliminating the need to divide tablets across multiple administrations. Taking the tablet at a consistent time each day — typically with the first meal — maintains steady plasma levels across the stack cycle. (2) angle_used

Manufacturer

Vital Research's market position within the European SARM research compound segment rests on a dual competitive advantage: catalogue breadth across chemically distinct SARM classes and a compound-specific quality documentation infrastructure that differentiates the brand from suppliers offering generic facility-wide quality statements. Each active ingredient in the portfolio — including RAD-140 — is treated as a standalone quality subject: its certificate of analysis is generated from lot-specific HPLC potency testing and LAL endotoxin screening rather than drawn from a shared batch record covering multiple compounds. This compound-individual approach to documentation is precisely what allows multi-SARM stack users to cross-reference certificates for each component independently, a practical requirement when running two or three Vital Research compounds simultaneously. The brand's standing among experienced SARM researchers in the UK and EU markets reflects this traceability architecture as much as product availability.